MILB 13G

Company

Protagenic Therapeutics, Inc.\new

Filed

February 1, 2005

Accession Number

0001051042-05-000009

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →